Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT [Phase 3]

View source ↗

Summary

A Phase III randomized trial is evaluating upfront cranial radiotherapy versus observation in patients with oncogene-mutated non-small cell lung cancer and asym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Asymptomatic Brain Metastases, Driver Mutation Positive Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING